Sign in

CIK 0001388320

  • Non-accelerated filer
  • Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880378336
Phone
+1 646-677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. 4 Open-market buy Principal Financial Officer bought 10,000 shares at $0.44 ($4,350)
  2. 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.45 ($4,499)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy CEO bought 10,000 shares at $0.79 ($7,900)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Principal Financial Officer bought 12,000 shares at $0.50 ($6,000)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy Chairman & CEO bought 5,000 shares at $0.38 ($1,900)
  14. 4 Other acquisition Chief Medical Officer acquired 14,000 shares (other)
  15. 4 Other acquisition Chairman & CEO acquired 52,500 shares (other)
  16. 4 Other acquisition Executive VP acquired 10,000 shares (other)
  17. 4 Other acquisition Director acquired 7,000 shares (other)
  18. 4 Other acquisition Principal Financial Officer acquired 10,000 shares (other)
  19. 4 Open-market buy Director bought 22,730 shares at $0.43 ($9,774)
  20. 3 Insider Initial Statement of Ownership

Page 4 of 8 · 146 filings